Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Fletcher

Showing results (131-140 of 205) with videos related to

Pageof 21
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2012
Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcomaBadreddin Edris, Kipp Weiskopf, Anne K Volkmer, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 10, 2003
The role of chromosomal translocation (15;19) in the carcinoma of the upper aerodigestive tract in childrenReza Rahbar, Sara O Vargas, Christopher R Miyamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2019
Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal TumorsCésar Serrano, Alessandro Leal, Yanan Kuang, et al.
Molecular Cancer Therapeutics|June 21, 2012
The HSP90 inhibitor, AT13387, is effective against imatinib-sensitive and -resistant gastrointestinal stromal tumor modelsTomoko Smyth, Thomas Van Looy, Jayne E Curry, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2013
Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growthBadreddin Edris, Stephen B Willingham, Kipp Weiskopf, et al.
The Journal of Clinical Investigation|October 9, 2002
PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesisDipak Panigrahy, Samuel Singer, Lucy Q Shen, et al.
Cancer Research|August 2, 2017
Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal TumorsWeicai Chen, Ye Kuang, Hai-Bo Qiu, et al.
Cancer Cell|June 13, 2006
Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancersIan J Davis, Jessica J Kim, Fatih Ozsolak, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2019
Mutational inactivation of mTORC1 repressor gene <i>DEPDC5</i> in human gastrointestinal stromal tumorsYuzhi Pang, Feifei Xie, Hui Cao, et al.
Oncology Letters|April 18, 2025
Ferroptosis as a therapeutic vulnerability in MDM2 inhibition in dedifferentiated liposarcomaChueh-Chuan Yen, Paul Chih-Hsueh Chen, San-Chi Chen, et al.
Pageof 21

Showing results (131-140 of 205) with videos related to

Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2012
Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcomaBadreddin Edris, Kipp Weiskopf, Anne K Volkmer, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 10, 2003
The role of chromosomal translocation (15;19) in the carcinoma of the upper aerodigestive tract in childrenReza Rahbar, Sara O Vargas, Christopher R Miyamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2019
Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal TumorsCésar Serrano, Alessandro Leal, Yanan Kuang, et al.
Molecular Cancer Therapeutics|June 21, 2012
The HSP90 inhibitor, AT13387, is effective against imatinib-sensitive and -resistant gastrointestinal stromal tumor modelsTomoko Smyth, Thomas Van Looy, Jayne E Curry, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2013
Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growthBadreddin Edris, Stephen B Willingham, Kipp Weiskopf, et al.
The Journal of Clinical Investigation|October 9, 2002
PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesisDipak Panigrahy, Samuel Singer, Lucy Q Shen, et al.
Cancer Research|August 2, 2017
Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal TumorsWeicai Chen, Ye Kuang, Hai-Bo Qiu, et al.
Cancer Cell|June 13, 2006
Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancersIan J Davis, Jessica J Kim, Fatih Ozsolak, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2019
Mutational inactivation of mTORC1 repressor gene <i>DEPDC5</i> in human gastrointestinal stromal tumorsYuzhi Pang, Feifei Xie, Hui Cao, et al.
Oncology Letters|April 18, 2025
Ferroptosis as a therapeutic vulnerability in MDM2 inhibition in dedifferentiated liposarcomaChueh-Chuan Yen, Paul Chih-Hsueh Chen, San-Chi Chen, et al.
Pageof 21